LAC 48:I.13615. HIV PrEP and PEP Documentation Requirements

A. Pharmacists shall document a focused assessment of the patient’s eligibility for HIV PrEP/PEP following best practices and guidelines for preventing HIV according to CDC Guidelines. B. Pharmacists shall document the patient’s written consent for HIV PrEP/PEP-related testing, counseling, administration, recordkeeping, and referrals. C. Pharmacists shall inform the patient's PCP of all test results and medications prescribed within 30 days of initiating HIV PrEP or PEP therapy with the patient’s explicit written consent to do so. D. If a patient does not consent to the release of their information or does not have a PCP, the pharmacist shall provide the patient with documentation of their test results and HIV PrEP or PEP medications and written information about providers and clinics from which they may seek ongoing care. E. Pharmacists shall inform the Department of Health of any reactive HIV, Hepatitis B/C, or other sexually transmitted infection test results using the procedures adopted by the Louisiana Department of Health in LAC 51.II.Chapter 1.Section 107. F. Pharmacists shall comply with all record-keeping requirements adopted by the Louisiana Board of Pharmacy in LAC 46.LIII.Chapter 11.Subchapter B. Sections 1119-1130.